🩸 New Publication Alert! 🧬 Learn about the latest strategies for selecting and managing #Myelofibrosis patients for allo-HCT. How to approach grey areas. 📖 Explore the full article: rdcu.be/dW0RR DrDonalMcLornan Nico Gagelmann Carmelo Gurnari #Hematology #MPNsm #BMTsm

Another important step in understanding pathogenesis of CD 🔬is out today : “Interleukin‐6 transcripts up‐regulation in lymph nodes from unicentric and multicentric Castleman disease” - Lucioni - eJHaem - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/jh…

Really honored to present transplant indications in unusual MPN and MDS/MPNs. Many thanks for inviting me! BSH - Haematology #myeloidneoplasia #BMTsm #BMT

#ASH24 | Linfoma follicolare R/R: arriva il dato a 4 anni di mosunetuzumab in monoterapia. Il commento a caldo di Luca Arcaini. A breve il commento completo sulla #Day3 🔜

Tutta la discografia dei Pink Floyd ma solo quando dicono il nome della canzone youtube.com/watch?v=NbUKU_…

👉👉👉Delighted to share our group’s new paper analyzing #TP53 impact & outcomes in patients with myeloid neoplasms 🚨 just out in Haematologica led by Dr Jayastu Senapati , Dr Sanam Loghavi, MD صنم لغوی 🔬🧬 & Dr Naval Daver, M.D. #leusm #endcancer haematologica.org/article/view/1…

January 2025 issue is available online. See and download for free the Haematologica Digital Edition! haematologica.org/preview/digita…

Pros and cons editorial: based on the results of the ASAP trial, Copelan and Gale suggest the current practice of pre-transplant re-induction therapy in relapsed acute myeloid leukemia lacks a strong scientific basis. haematologica.org/article/view/h…

Mina + Francesco Gabbani (qui nessuno ha bisogno dell'autotune) youtu.be/3N0CPJyYQfM

“The End of the Golden Weather”: therapeutic strategies for mantle cell lymphoma relapsed or refractory to covalent BTK inhibitors | Haematologica haematologica.org/article/view/1…

Fresh of the press @BloodJournal „Allo HCT in „nonclassical“ MPNs and MDS/MPNs“ Fantastic global consensus project led by Nicola Polverelli, MD, PhD and DrDonalMcLornan !…always a pleasure to work with the dedicated team of The EBMT CMWP!! ashpublications.org/blood/article/…

Very honored to share The EBMT recommendations for the management and #alloHCT of atypical #MDSMPN and #MPN, just published in @BloodJournal 👉doi.org/10.1182/blood.… Many thanks to all the authors for this great result! DrDonalMcLornan Nico Gagelmann Katja Sockel Naveen Pemmaraju, MD

#RASSEGNASTAMPA #Linfoma #DLBCL: terapie CAR-T e cure sempre più efficaci. A Osservatorio Terapie Avanzate e OMaR Malattie Rare ne parla Michele Merli, specialista dell'#Ematologia - diretta dal Prof. Francesco Passamonti - di #PoliclinicoMi ➡ bit.ly/3Rv8Fut

🎊Happy to share our latest publication on the role of cryopreservation in alloHCT!! onlinelibrary-wiley-com.proxy.unibs.it/doi/10.1002/aj… GITMOTwitting

Fantastic Marginal Zone Lymphoma ‘Meet the Professor’ session Soni Smith MD An excellent oversight of factors influencing management decisions 👏 #ICML2025

Ajay Major, MD, MBA For our friends and our colleagues, especially those in community oncology, if you had the proverbial gun to your head, and you really had to chose between either MRD at End of Rx vs any or all of these various genetic classifiers to define 5/6/7/8 DLBCL subtypes as proposed by

Pros and cons: in the ATRA and ATO era, do we need maintenance therapy for high-risk acute promyelocytic leukemia? Read the PROS by Martin S. Tallman. haematologica.org/article/view/1…

Excellent iNHL session tonight at #IACH 🇫🇷 with Stefano Luminari, MD Jessica Okosun Julio Chavez 🤩 Cc Andrew M. Evens, DO, MBA, MSc Luca Arcaini Anna Sureda